| 摘要 |
The present invention involves the production of large quantities of human alpha -Gal A by cloning and expressing the alpha -Gal A coding sequence in eukaryotic host cell expression systems. The eukaryotic expression systems, and in particular the mammalian host cell expression system described herein provide for the appropriate cotranslational and posttranslational modifications required for proper processing, e.g., glycosylation, phosphorylation, etc. and sorting of the expression product so that an glycosylation, phosphorylation, etc. and sorting of the expression product so that an active enzyme is produced. In addition, the expression of fusion proteins which simplify purification is described. Using the methods described herein, the recombinant alpha -Gal A is secreted by the engineered host cells so that it is recovered from the culture medium in good yield. The alpha -Gal A produced in accordance with the invention may be used in the treatment in Fabry Disease; for the hydrolysis of alpha -galactosyl residues in glycoconjugates; and/or for the conversion of the blood group B antigen on erythrocytes to the blood group O antigen.
|
